Enzypep Overview
- Year Founded
-
2012
- Status
-
Out of Business
- Employees
-
4
- Latest Deal Type
-
Out of Business
- Investors
-
1
Enzypep General Information
Description
Developer of peptide ligation technology designed to offer the synthesis of oligopeptides. develops green, sustainable and cost-effective routes to synthesize pharmaceutical peptides and bioconjugates using its proprietary CEPS (Chemo Enzymatic Peptide Synthesis) and PECON (Protein Enzymatic CONjugation) toolbox, enabling companies to create pharmaceutical products with much higher purity, at a much lower cost and in a sustainable, environmentally-friendly manner.
Contact Information
Website
www.enzypep.comCorporate Office
- Brightlands Campus
- Building 93. Room 093.3.220, Urmonderbaan 22
- 6167 RD Geleen
- Netherlands
Corporate Office
- Brightlands Campus
- Building 93. Room 093.3.220, Urmonderbaan 22
- 6167 RD Geleen
- Netherlands
Enzypep Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 01-Jan-2019 | Completed | Out of Business | |||
| 2. Early Stage VC | 01-Jan-2015 | Completed | Startup | |||
| 1. Early Stage VC | 01-Jun-2012 | Completed | Startup |
Enzypep Patents
Enzypep Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024208687-A1 | Method for the preparation of lactulose | Inactive | 06-Apr-2023 | ||
| WO-2024133313-A1 | Thermostable subtilisin variants and their use | Inactive | 19-Dec-2022 | ||
| WO-2019170918-A1 | Chemo-enzymatic synthesis of liraglutide, semaglutide and glp-1 | Inactive | 09-Mar-2018 | ||
| WO-2019170895-A1 | Chemo-enzymatic synthesis of semaglutide, liraglutide and glp-1 | Inactive | 09-Mar-2018 | ||
| CA-3060389-A1 | Subtilisin variants having a mutation in the s2 or s2' pocket | Active | 19-May-2017 | C12N9/52 |
Enzypep Signals
Enzypep Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Rijksdienst voor Ondernemend Nederland | Government | Minority |
Enzypep Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| EnzyTag | Nuth, Netherlands | 2018 |
Enzypep FAQs
-
When was Enzypep founded?
Enzypep was founded in 2012.
-
Where is Enzypep headquartered?
Enzypep is headquartered in Geleen, Netherlands.
-
What is the size of Enzypep?
Enzypep has 4 total employees.
-
What industry is Enzypep in?
Enzypep’s primary industry is Biotechnology.
-
Is Enzypep a private or public company?
Enzypep is a Private company.
-
What is Enzypep’s current revenue?
The current revenue for Enzypep is .
-
How much funding has Enzypep raised over time?
Enzypep has raised $4.91M.
-
Who are Enzypep’s investors?
Rijksdienst voor Ondernemend Nederland has invested in Enzypep.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process